Home / Business and Economy / Moderna Surges 177% on Unknown Catalyst
Moderna Surges 177% on Unknown Catalyst
20 Aug
Summary
- Moderna's stock saw a remarkable 177.87% surge, reaching $174.95.
- Merck's shares climbed to all-time highs, closing at $152.23.
- Major indices like the Dow, S&P 500, and Nasdaq closed higher.
U.S. stock markets concluded Wednesday's trading session on an upward trajectory. The Dow Jones Industrial Average saw a 0.22% increase, the S&P 500 climbed by 0.22%, and the NASDAQ Composite gained 0.16%.
Leading the market's advance was Moderna Inc. (NASDAQ:MRNA), which experienced an extraordinary surge of 177.87%, reaching $174.95 and marking a three-year high. Merck & Company Inc. (NYSE:MRK) also reached all-time highs, gaining 12.62% to close at $152.23.
Other notable performers included Salesforce Inc. and Amgen Inc., which both saw significant gains. Conversely, Caterpillar Inc. and Honeywell International Inc. were among the session's decliners.
The CBOE Volatility Index decreased by 6.00% to 14.89. In commodities, Gold Futures rose 3.57% to $4,578.46 per ounce, while crude oil prices also saw modest increases. Currency markets showed EUR/USD up 0.86% to 1.17 and USD/JPY down 0.88% to 158.21.
